Frederick Lahser

Statistics

Publications

Citations

1.3K

H-Index

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

PTC Therapeutics (United States)

Stony Brook University

WuXi AppTec (China)

State University of New York

Frederick Lahser is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in molecular virology, virology, and viral hepatitis.

ORCID

Publications per year

1993–2019

Publications

SCH 503034, a Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease, Suppresses Polyprotein Maturation and Enhances the Antiviral Activity of Alpha Interferon in Replicon Cells

Bruce A. Malcolm, R. Liu, Frederick Lahser et al. · Antimicrobial Agents and Chemotherapy · 2006 · 318 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors

David R. McGivern, Takahiro Masaki, Sara E. Williford et al. · Gastroenterology · 2014 · 109 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

A Protein Linkage Map of the P2 Nonstructural Proteins of Poliovirus

Andrea Cuconati, Wenkai Xiang, Frederick Lahser et al. · Journal of Virology · 1998 · 70 citations · Full text

Life Sciences, Microbiology, Molecular Biology +16

The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons

Frederick Lahser, Karin Bystol, Stephanie Curry et al. · Antimicrobial Agents and Chemotherapy · 2016 · 58 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Contributions of the brome mosaic virus RNA-3 3'-nontranslated region to replication and translation

Frederick Lahser, Loren E. Marsh, Timothy C. Hall · Journal of Virology · 1993 · 57 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

1–5 of 29